AstraZeneca Pharma Share Price | AstraZeneca Pharma Stock Screener
ASTRAZEN
Pharmaceuticals
Share Price NSE
₹7872.00
▼
-159.00 (-1.98%)
Share Price BSE
₹7873.60
▼
-159.45 (-1.98%)
As of July 23, 2026, the AstraZeneca Pharma share price (NSE: ASTRAZEN) is ₹7,872.00 on NSE and ₹7,873.60 on BSE, down 1.98% from the previous close, with shares trading between ₹7,850.00 and ₹8,048.50, and a 52-week range of ₹7,765.50–₹9,827.50.
Analyse ASTRAZEN price trends and track historical price performance.
Use the AstraZeneca Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
AstraZeneca Pharma Market Cap
₹20,058.75 Cr.
ASTRAZEN P/E Ratio (TTM)
107.88
AstraZeneca Pharma P/B Ratio
23.18
EPS (TTM)
₹46.30
Dividend Yield
0.44%
Debt to Equity
0.03
ASTRAZEN 52 Week High
₹9827.50
AstraZeneca Pharma 52 Week Low
₹7765.50
Operating Margin
15.00%
Profit Margin
6.60%
ASTRAZEN Revenue (TTM)
₹1,757.00
EBITDA
₹295.00
Net Income
₹116.00
Total Assets
₹1,989.00
Total Equity
₹873.00
AstraZeneca Pharma Share Price Chart
Screen AstraZeneca Pharma share price with an interactive chart. Analyse ASTRAZEN price trends and volatility across different timeframes.
AstraZeneca Pharma Company Profile - Fundamental Screener
Screen AstraZeneca Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ASTRAZEN shares.
AstraZeneca Pharma India Limited is a biopharmaceutical company incorporated in 1979. It manufactures, distributes, and markets pharmaceutical products, focusing on cardiovascular, renal and metabolism, oncology, and respiratory diseases. The company operates in the healthcare segment and provides clinical trial services to an overseas group company. Key products include Forxiga for...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Shilpa Divekar Nirula
ISIN
INE203A01020
Website
https://www.astrazeneca.in
AstraZeneca Pharma Balance Sheet Screener
Screen ASTRAZEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,989 | 1,518 | 1,078 | 985 | 857 | 775 | 706 | 562 | 461 | 416 |
| Current Assets | 1,740 | 1,342 | 933 | 836 | 706 | 619 | 542 | 405 | 321 | 252 |
| Fixed Assets | 118 | 64 | 67 | 69 | 75 | 81 | 72 | 75 | 76 | 87 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 135 | 45 | 9 | 12 | 13 | 15 | 15 | 2 | 7 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 873 | 770 | 712 | 589 | 511 | 456 | 364 | 301 | 247 | 223 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 868 | 765 | 707 | 584 | 506 | 451 | 359 | 296 | 242 | 218 |
AstraZeneca Pharma Income Statement Screener - Profit & Revenue Analysis
Screen AstraZeneca Pharma income statement and profit fundamentals.
Analyze ASTRAZEN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for AstraZeneca Pharma share price evaluation.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,757 | 1,330 | 1,029 | 820 | 826 | 845 | 745 | 583 | 558 | 571 | 523 |
| Expenses | 1,462 | 1,111 | 838 | 719 | 678 | 711 | 657 | 525 | 507 | 547 | 529 |
| EBITDA | 295 | 219 | 191 | 101 | 148 | 134 | 88 | 59 | 51 | 23 | -6 |
| Operating Profit % | 15.00% | 14.00% | 16.00% | 11.00% | 17.00% | 15.00% | 10.00% | 8.00% | 7.00% | 3.00% | -2.00% |
| Depreciation | 40 | 15 | 16 | 17 | 20 | 19 | 15 | 15 | 16 | 17 | 15 |
| Interest | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 156 | 220 | 134 | 83 | 127 | 114 | 73 | 44 | 36 | 6 | -21 |
| Tax | 41 | 58 | 35 | 21 | 34 | 42 | 18 | 18 | 15 | 1 | 0 |
| Net Profit | 116 | 162 | 99 | 62 | 93 | 72 | 54 | 26 | 20 | 5 | -21 |
| EPS | 46.30 | 64.60 | 39.70 | 24.60 | 37.30 | 28.90 | 21.80 | 10.40 | 8.00 | 2.10 | -8.34 |
AstraZeneca Pharma Cash Flow Screener - Liquidity Fundamentals
Screen ASTRAZEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 65 | 28 | 58 | 101 | 105 | 87 | 55 | 9 | 38 | 57 |
| Investing Activities | 31 | 22 | 18 | 5 | 173 | -171 | 4 | -9 | 0 | -4 |
| Financing Activities | -66 | -44 | -25 | -10 | -9 | -6 | 0 | 0 | 0 | -1 |
| Net Cash Flow | 31 | 5 | 52 | 96 | 269 | -90 | 59 | -1 | 38 | 53 |
AstraZeneca Pharma Shareholding Pattern Screener
See AstraZeneca Pharma shareholding pattern with promoter, FII, and DII holdings.
Check AstraZeneca Pharma promoter holding and ownership changes for ASTRAZEN on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| FII Holding | 2.78% | 2.89% | 3.03% | 2.74% | 2.71% | 2.74% | 2.79% | 2.90% |
| DII Holding | 5.80% | 4.65% | 4.56% | 5.26% | 5.56% | 3.78% | 5.01% | 5.10% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.88% | 15.16% | 15.18% | 14.39% | 14.14% | 16.33% | 15.00% | 14.77% |
| Other Holding | 2.55% | 2.31% | 2.23% | 2.61% | 2.59% | 2.15% | 2.20% | 2.23% |
| Shareholder Count | 29,007 | 32,466 | 34,378 | 32,914 | 31,551 | 29,418 | 27,169 | 27,615 |
AstraZeneca Pharma Share Dividend Screener - Share Yield Analysis
Check AstraZeneca Pharma dividend history with payout and yield data.
View AstraZeneca Pharma dividend details including ex-dates and amounts for ASTRAZEN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹32.00 | 0.41% |
| 2024-March | ₹24.00 | 0.28% |
| 2023-March | ₹16.00 | 0.30% |
| 2022-March | ₹10.00 | 0.31% |
| 2021-March | ₹2.00 | 0.08% |
| 2020-March | ₹1.00 | 0.03% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
AstraZeneca Pharma Stock Index Membership
See which indices include AstraZeneca Pharma stock.
Check ASTRAZEN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100
NIFTY MIDSML 400
NIFTY SMALLCAP250 MOMENTUM QUALITY 100
NIFTY SMALLCAP250 QUALITY 50
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 MULTICAP MOMENTUM QUALITY 50
NIFTY500 SHARIAH
AstraZeneca Pharma Market Events Screener - Corporate Actions
Get AstraZeneca Pharma corporate actions including splits, bonuses, and buybacks.
Check AstraZeneca Pharma stock events that may affect ASTRAZEN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | 1.20% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 4.80% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -1.29% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -6.00% |
| 2025-08-14 | 2025-08-14 | Annual General Meeting | NA | -4.71% |
| 2025-07-18 | 2025-07-18 | Dividend | ₹ 32.00 /share | 18.54% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -0.03% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | 8.88% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 3.57% |
| 2024-08-08 | 2024-08-08 | Annual General Meeting | NA | 7.26% |
| 2024-07-05 | 2024-07-05 | Dividend | ₹ 24.00 /share | 18.44% |
| 2023-07-14 | 2023-07-14 | Dividend | ₹ 16.00 /share | 15.81% |
| 2022-08-08 | 2022-08-08 | Annual General Meeting | NA | 3.23% |
| 2022-07-07 | 2022-07-08 | Dividend | ₹ 8.00 /share | 10.01% |
| 2021-08-18 | 2021-08-20 | Dividend | ₹ 2.00 /share | -8.95% |
AstraZeneca Pharma Competitors Screener - Peer Comparison
Screen ASTRAZEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 463,695 | 40.65 | 61,674 | 12.69% | 11,565 | 62.67 |
| Divis Laboratories | 192,398 | 75.67 | 10,560 | 8.73% | 2,520 | 69.61 |
| Torrent Pharmaceuticals | 181,169 | 79.18 | 13,886 | 20.34% | 2,138 | 53.08 |
| Zydus Life Science | 115,083 | 22.46 | 27,658 | 17.64% | 5,026 | 59.19 |
| Cipla | 114,609 | 29.90 | 29,045 | 2.24% | 3,870 | 48.42 |
| Lupin | 111,711 | 21.34 | 29,039 | 26.75% | 5,356 | 54.70 |
| Mankind Pharma | 102,596 | 54.23 | 14,636 | 14.85% | 1,938 | 50.34 |
| Dr Reddys Laboratories | 101,095 | 24.57 | 35,059 | 3.90% | 4,158 | 31.90 |
| Aurobindo Pharma | 88,228 | 25.67 | 33,385 | 3.21% | 3,376 | 50.49 |
| Laurus Labs | 82,587 | 94.51 | 6,868 | 22.01% | 890 | 59.60 |
AstraZeneca Pharma Company Announcements - News Screener
Screen ASTRAZEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-23 | Record Date For Payment Of Final Dividend | - |
| 2026-07-23 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-07-23 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-07-23 | Reg. 34 (1) Annual Report. | - |
| 2026-07-23 | Notice Of The 47Th Annual General Meeting | - |
| 2026-07-21 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 | - |
| 2026-07-06 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel (SMP) | - |
| 2026-06-16 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel | - |
| 2026-06-15 | Closure of Trading Window | - |
| 2026-06-12 | Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Resignation Of Senior Management Personnels | - |
| 2026-06-11 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 | - |
| 2026-06-04 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-06-03 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 | - |
| 2026-06-01 | Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Resignation Of Senior Management Personnel | - |
| 2026-05-29 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-26 | Outcome Of The Board Meeting Held On Tuesday May 26 2026 | - |
| 2026-05-21 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 | - |
| 2026-05-20 | Determination Of Materiality - Details Of Key Managerial Personnel | - |
| 2026-05-20 | Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Tuesday May 26 2026 | - |